3 completed, 1 recruiting, 1 unknown. 3 Phase 3, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Not applicable | 2 | Recruiting 1, Unknown 1 |
Follow Paralysis, Hyperkalemic Periodic: new trials by email Literature Review of Paralysis, Hyperkalemic Periodic trials Research Report on Paralysis, Hyperkalemic Periodic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Physical Training in Individuals With Hypokalemic and Hyperkalemic Periodic Paralysis Strength exercise - Hypokalemic Periodic Paralysis, Hyperkalemic Periodic Paralysis | Not applicable | Recruiting | Copenhagen University Hospital, Rigshospitalet | 36 | 2025-10-02 | 2026-03-30 |
| Treatment of Myotonia - Lamotrigine Versus Namuscla Lamotrigine, Namuscla - Non-Dystrophic Myotonia | Not applicable | Unknown | Grete Andersen, MD | 32 | 2022-12-05 | 2022-12-06 |
| Lamotrigine as Treatment of Myotonia Lamotrigine, Placebo - Dystrophia Myotonica Type 1, Myotonia Congenita | Phase 3 | Completed | Grete Andersen, MD | 27 | 2013-11-01 | 2016-04-25 |
| Hyper- and Hypokalemic Periodic Paralysis Study Dichlorphenamide (double-blind), Placebo (double-blind), Dichlorphenamide (open-label) - Hyperkalemic Periodic Paralysis, Hypokalemic Periodic Paralysis | Phase 3 | Completed | University of Rochester | 71 | 2007-06-01 | 2017-06-14 |
| Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders dichlorphenamide - Paralysis, Hyperkalemic Periodic, Hypokalemic Periodic Paralysis | Phase 3 | Completed | National Center for Research Resources (NCRR) | 64 | 1992-06-01 | 2005-06-24 |
Hypokalemic Periodic Paralysis (3) · Myotonic Disorders (2) · Mental Disorders (1) · Myotonia (1) · Myotonia Congenita (1) · Myotonic Dystrophy (1) · Neurologic Manifestations (1) · Potassium aggravated myotonia (1) · Rare Diseases (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5) · Genetic Diseases, Inborn (5) · Metabolic Diseases (5) · Metabolism, Inborn Errors (5) · Metal Metabolism, Inborn Errors (5) · Muscular Diseases (5) · Musculoskeletal Diseases (5) · Nervous System Diseases (5) · Neuromuscular Diseases (5) · Nutritional and Metabolic Diseases (5) · Paralyses, Familial Periodic (5) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Disease Attributes (1) · Heredodegenerative Disorders, Nervous System (1)
Dichlorphenamide (2) · Lamotrigine (2) · Double-Blind Method (1) · Mexiletine (1)
Grete Andersen, MD (2) · Copenhagen University Hospital, Rigshospitalet (1) · National Center for Research Resources (NCRR) (1) · University of Rochester (1)
Denmark (3) · Italy (1) · United Kingdom (1) · United States (1)
Grete Andersen, MD (1) · Jerry R. Mendell (1) · Michael McDermott, Ph.D. (1) · Rabi Tawil, M.D. (1) · Robert C. Griggs, M.D. (1)